Skip to main content
Equibles

Jack E. Stover

Chairman

Traws Pharma, Inc. (TRAW)

Board Member

Transcode Therapeutics, Inc. (RNAZ)

Board Member

Interpace Biosciences, Inc. (IDXG)

Equibles does not estimate personal net worth.

About Jack E. Stover

Jack E. Stover is recorded as Chairman at Traws Pharma, Inc. (TRAW), Board Member at Transcode Therapeutics, Inc. (RNAZ) since January 1, 2025 and Board Member at Interpace Biosciences, Inc. (IDXG) since July 9, 2020. The newest filing on record that lists Jack E. Stover as Chairman at Traws Pharma, Inc. (TRAW) is dated May 29, 2026. The newest filing on record that lists Jack E. Stover as Board Member at Transcode Therapeutics, Inc. (RNAZ) is dated June 2, 2026. Traws Pharma, Inc. reported in an 8-K filed July 9, 2026 that Jack E. Stover was appointed Director, effective July 8, 2026. Traws Pharma, Inc. reported in an 8-K filed November 28, 2025 that Jack E. Stover was appointed director, effective November 21, 2025. Interpace Biosciences, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Transcode Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Interpace Biosciences, Inc. includes Thomas Burnell (CEO), Thomas W. Burnell (CEO and Board Member), Christopher McCarthy (CFO) and 7 others.

“Each nominee for director was elected by a vote of the stockholders as follows:”
Traws Pharma, Inc. Form 8-K, filed July 9, 2026 · Read the filing
“To elect seven directors, each to hold office until the Company’s 2026 Annual Meeting of Stockholders and until his or her successor is elected and qualified.”
Traws Pharma, Inc. Form 8-K, filed November 28, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at Interpace Biosciences, Inc.

Leadership on record at Transcode Therapeutics, Inc.

Leadership on record at Traws Pharma, Inc.

Recent activity